We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+26.99%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12.5B
AUM Growth
+$844M
Cap. Flow
-$1.62B
Cap. Flow %
-12.95%
Top 10 Hldgs %
33.14%
Holding
137
New
32
Increased
25
Reduced
37
Closed
18

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$331M
2
AON icon
Aon
AON
+$321M
3
WUBA
58.com Inc
WUBA
+$256M
4
BMY icon
Bristol-Myers Squibb
BMY
+$217M
5
TIF
Tiffany & Co.
TIF
+$191M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.65B
2
CI icon
Cigna
CI
+$142M
3
FIS icon
Fidelity National Information Services
FIS
+$135M
4
GD icon
General Dynamics
GD
+$132M
5
WAB icon
Wabtec
WAB
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 42.53%
2 Communication Services 18.4%
3 Technology 10.42%
4 Financials 7.52%
5 Industrials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
101
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$3.83M 0.03%
+750,000
New +$3.12M
DMTK
102
DELISTED
DermTech, Inc. Common Stock
DMTK
$2.58M 0.02%
194,675
-410,580
-68% -$5.35M
BRMK.WS
103
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$2.28M 0.02%
7,174,613
– –
RNAM
104
DELISTED
Avidity Biosciences
RNAM
$1.41M 0.01%
+50,000
New +$1.44M
GOSS icon
105
Gossamer Bio
GOSS
$87M
$1.3M 0.01%
100,000
– –
CTMX icon
106
CytomX Therapeutics
CTMX
$754M
$1.24M 0.01%
+148,952
New +$1.38M
GOL
107
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$582K ﹤0.01%
85,838
– –
ATRA icon
108
Atara Biotherapeutics
ATRA
$76.1M
– –
-60,000
Closed -$12.8M
BEAM icon
109
Beam Therapeutics
BEAM
$2.84B
– –
-170,164
Closed -$3.06M
OPTN
110
DELISTED
OptiNose
OPTN
– –
-52,032
Closed -$3.5M
RVMD icon
111
Revolution Medicines
RVMD
$44B
– –
-20,733
Closed -$454K
SPY icon
112
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
– –
-2,616,500
Closed -$722M
VSTM icon
113
Verastem
VSTM
$610M
– –
-310,078
Closed -$9.82M
XRX icon
114
Xerox
XRX
$425M
– –
-130,000
Closed -$2.46M
EIGR
115
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-1,670
Closed -$341K
AGTC
116
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-586,497
Closed -$1.92M
PHAS
117
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-84,502
Closed -$280K
QTNT
118
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-62,500
Closed -$9.88M
ADSW
119
DELISTED
Advanced Disposal Services Inc
ADSW
– –
-176,610
Closed -$5.79M
MNTA
120
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-842,683
Closed -$22.9M
PGNX
121
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-8,250,000
Closed -$31.4M
STML
122
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-2,350,000
Closed -$11.4M
AGN
123
DELISTED
Allergan plc
AGN
– –
-9,300,000
Closed -$1.65B
FTSV
124
DELISTED
Forty Seven, Inc. Common Stock
FTSV
– –
-1,105,000
Closed -$105M
RARX
125
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-1,440,000
Closed -$69.1M
1 2 3 4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Farallon Capital Management held 137 positions worth $12.5B, up 7.2% from $11.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management withdrew a net $1.62B in Q2 2020, closing 18 positions and reducing 37 holdings. Its most notable exit was Allergan plc, an estimated $1.65B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 52% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Farallon Capital Management opened a new position in T-Mobile US worth $360M.

  • Farallon Capital Management's largest Q2 2020 buy was T-Mobile US: 3,457,631 shares worth $360M.
  • Farallon Capital Management added most to Blackstone in Q2 2020, an estimated $125M increase.
  • Farallon Capital Management's biggest Q2 2020 reduction was Cigna, cutting an estimated $142M.
  • Farallon Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $1.65B.
  • Farallon Capital Management's ten largest holdings make up 33% of its $12.5B portfolio in Q2 2020.
  • Farallon Capital Management opened 32 new positions and closed 18 in Q2 2020.
  • Farallon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $12.5B.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.